Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma

被引:0
作者
Khaled Mohieldeen
Soraya Abdel Fatah Hamoda
Shwikar Mahmoud Ahmed
Abdurrahman Najeeb
Walid Ismail Ellakany
机构
[1] Alexandria University,Tropical Medicine Department, Faculty of Medicine
[2] Alexandria University,Medical Microbiology and Immunology Department, Faculty of Medicine
来源
Egyptian Liver Journal | / 11卷
关键词
Cirrhosis; Hepatitis C virus; Hepatocellular carcinoma; Gut dysbiosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 296 条
  • [1] Waked I(2020)Screening and treatment program to eliminate hepatitis C in Egypt N Engl J Med 382 1166-1174
  • [2] Esmat G(2015)Gut microbiome: what we do and don’t know Nutr Clin Pract 30 734-746
  • [3] Elsharkawy A(2017)Microbes and cancer Annu Rev Immunol 35 199-228
  • [4] El-Serafy M(2015)Cancer and the microbiome: potential applications as new tumor biomarker Expert Rev Anticancer Ther 15 317-330
  • [5] Abdel-Razek W(2012)Intestinal inflammation targets cancer-inducing activity of the microbiota Science 338 120-123
  • [6] Ghalab R(2015)Cancer and the gut microbiota: an unexpected link Sci Transl Med 7 271ps1-ps1-539
  • [7] Cresci GA(2017)The gut microbiome and liver cancer: mechanisms and clinical translation Nat Rev Gastroenterol Hepatol 14 527-388
  • [8] Bawden E(2019)The microbiome, cancer, and cancer therapy Nat Med 25 377-478
  • [9] Dzutsev A(2020)The impact of modulating the gastrointestinal microbiota in cancer patients Best Pract Res Clin Gastroenterol 101700 101700-943
  • [10] Badger JH(2017)Anticancer effects of the microbiome and its products Nat Rev Microbiol 15 465-544